RecruitingPhase 2NCT06680830
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Sponsor: Neuron23 Inc.
Fresno, CA · Irvine, CA · Los Angeles, CA · +42 more sites
2 recruiting parkinson's disease studies with a site in Murrieta, CA.
Sponsor: Neuron23 Inc.
Fresno, CA · Irvine, CA · Los Angeles, CA · +42 more sites
Sponsor: Vima Therapeutics
Murrieta, CA · +28 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.